0
BU Score
Niche
RapidASCVD: ASCVD Risk Calc
✍️ bumetric analysis
“
RapidASCVD: ASCVD Risk Calc is an iOS app from ClinCalc LLC in the Education category, currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Our BU Score puts it at 0: Niche (micro-niche or pre-traction stage). For a Education app, that means micro-niche or pre-traction stage.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 3 of 3 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.99)METRIC | +$2,800 | |
| Established app (5y old)METRIC | +$800 | |
| Single-language (English only)METRIC | −$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🗓️ Snapshot Timeline
HISTORYEach bar shows a tracked update and the metric delta from the previous snapshot.
App Specs
🔐 Own this app? Claim & verify MRR →💾 2 MB🔞 17+📱 iOS 13.0+🔖 v1.1🔄 updated 1y ago🌐 EN📂 Education💰 Paid🚀 Launched 2020 (5y old)
📝 About this app
RapidASCVD accurately estimates 10-year ASCVD (atherosclerotic cardiovascular disease). The user interface has been optimized for speed so that busy clinicians are able to quickly calculate ASCVD scores for patients in the fastest amount of time possible -- usually within about 10-15 seconds.
ASCVD risk is the estimated probability of a patient having a first-time (primary) event of coronary heart disease (such as myocardial infarction), cerebrovascular disease (such as stroke), and peripheral arterial disease. This estimate is not appropriate for use in patients who have already had one of these cardiovascular events.
RapidASCVD has been extensively tested for accuracy with the pooled cohort equations (2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. doi: 10.1161/01.cir.0000437741.48606.98), which is derived from the following variables:
• Age
• Total cholesterol
• HDL cholesterol
• Systolic blood pressure
• Sex
• Race
• Presence of antihypertensive therapy
• History of diabetes mellitus
• Current smoking status
The risk estimate is consistent with the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (doi: 10.1161/CIR.0000000000000678), acknowledging that many other cardiovascular risk factors exist that are not present in the ASCVD risk calculation. This clinical tool is intended to be used in conjunction with reasonable clinical judgment.
ASCVD risk is the estimated probability of a patient having a first-time (primary) event of coronary heart disease (such as myocardial infarction), cerebrovascular disease (such as stroke), and peripheral arterial disease. This estimate is not appropriate for use in patients who have already had one of these cardiovascular events.
RapidASCVD has been extensively tested for accuracy with the pooled cohort equations (2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. doi: 10.1161/01.cir.0000437741.48606.98), which is derived from the following variables:
• Age
• Total cholesterol
• HDL cholesterol
• Systolic blood pressure
• Sex
• Race
• Presence of antihypertensive therapy
• History of diabetes mellitus
• Current smoking status
The risk estimate is consistent with the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (doi: 10.1161/CIR.0000000000000678), acknowledging that many other cardiovascular risk factors exist that are not present in the ASCVD risk calculation. This clinical tool is intended to be used in conjunction with reasonable clinical judgment.
🆕 What's New · v1.1
Updates for the latest version of iOS
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- RapidASCVD: ASCVD Risk Calc
- Developer
- ClinCalc LLC
- Bundle ID
- com.clincalc.rapidascvd
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- clincalc.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Outside top 99 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
- Name
- Not found
- X / Twitter
- Not found
- Not found
- GitHub
- Not found
- X followers
- Not found
- Public statements
- Not found
Funding
- Total raised
- Not found
- Last round
- Not found
- Investors
- Not found
- Crunchbase
- Not found
- AngelList
- Not found
Press & Links
- Articles found
- Not found
- Listed on
- Not found
- Blog
- Not found
- Press / News
- Not found
Contacts & Socials
- Socials
- Not found
- Not found
- Phone
- Not found
- Contact page
- Not found
- About page
- Not found
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
